|
|
||||||||
1Division of Nephrology, Department of Internal Medicine, Veterans Affairs Ann Arbor Healthcare System and University of Michigan, Ann Arbor, Michigan; and 2Division of Nephrology and Hypertension, Department of Internal Medicine, University Hospital Essen, Essen, Germany
Submitted 29 July 2005 ; accepted in final form 31 August 2005
Kidney proximal tubules exhibit decreased ATP and reduced, but not absent, mitochondrial membrane potential (
m) during reoxygenation after severe hypoxia. This energetic deficit, which plays a pivotal role in overall cellular recovery, cannot be explained by loss of mitochondrial membrane integrity, decreased electron transport, or compromised F1F0-ATPase and adenine nucleotide translocase activities. Addition of oleate to permeabilized tubules produced concentration-dependent decreases of 
m measured by safranin O uptake (threshold for oleate = 0.25 µM, 1.6 nmol/mg protein; maximal effect = 4 µM, 26 nmol/mg) that were reversed by delipidated BSA (dBSA). Cell nonesterified fatty acid (NEFA) levels increased from <1 to 17.4 nmol/mg protein during 60- min hypoxia and remained elevated at 7.6 nmol/mg after 60 min reoxygenation, at which time ATP had recovered to only 10% of control values. Safranin O uptake in reoxygenated tubules, which was decreased 85% after 60-min hypoxia, was normalized by dBSA, which improved ATP synthesis as well. dBSA also almost completely normalized 
m when the duration of hypoxia was increased to 120 min. In intact tubules, the protective substrate combination of
-ketoglutarate + malate (
-KG/MAL) increased ATP three- to fourfold, limited NEFA accumulation during hypoxia by 50%, and lowered NEFA during reoxygenation. Notably, dBSA also improved ATP recovery when added to intact tubules during reoxygenation and was additive to the effect of
-KG/MAL. We conclude that NEFA overload is the primary cause of energetic failure of reoxygenated proximal tubules and lowering NEFA substantially contributes to the benefit from supplementation with
-KG/MAL.
acute renal failure; kidney; mitochondrial membrane potential
This article has been cited by other articles:
![]() |
J. M. Weinberg and B. A. Molitoris Illuminating Mitochondrial Function and Dysfunction using Multiphoton Technology J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1164 - 1166. [Full Text] [PDF] |
||||
![]() |
T. Feldkamp, J. M. Weinberg, M. Horbelt, C. Von Kropff, O. Witzke, J. Nurnberger, and A. Kribben Evidence for involvement of nonesterified fatty acid-induced protonophoric uncoupling during mitochondrial dysfunction caused by hypoxia and reoxygenation Nephrol. Dial. Transplant., January 1, 2009; 24(1): 43 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Zager, A. C. M. Johnson, M. Naito, and K. Bomsztyk Maleate nephrotoxicity: mechanisms of injury and correlates with ischemic/hypoxic tubular cell death Am J Physiol Renal Physiol, January 1, 2008; 294(1): F187 - F197. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Mehta Glycemic Control and Critical Illness: Is the Kidney Involved? J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2623 - 2627. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Feldkamp, A. Kribben, N. F. Roeser, T. Ostrowski, and J. M. Weinberg Alleviation of fatty acid and hypoxia-reoxygenation-induced proximal tubule deenergization by ADP/ATP carrier inhibition and glutamate Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1606 - F1616. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |